Nektar Therapeutics NKTR Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's common stock, par value (in dollars per share)?
- Nektar Therapeutics (NKTR) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Nektar Therapeutics's common stock, par value (in dollars per share) changed year-over-year?
- Nektar Therapeutics's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Nektar Therapeutics's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Nektar Therapeutics's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.